Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jul. 26, 2013	Jul. 27, 2012
OPERATING ACTIVITIES:
Net income (loss)	$ 225,745	$ 218,728
Adjustments to reconcile net income (loss) to net cash (used in)/provided by operating activities:
Depreciation	57,128	63,677
Amortization	4,900	4,939
Stock-based compensation	12,783	7,735
(Gain)/loss on asset divestitures	(518)	1,043
Changes in certain assets and liabilities, net of effects of acquired businesses:
(Increase)/decrease in accounts and notes receivable	(44,460)	(85,276)
(Increase)/decrease in inventories and other assets	(85,822)	(60,848)
Increase/(decrease) in trade accounts payable and other accrued liabilities	29,831	28,703
Increase/(decrease) in income taxes payable	5,706	10,173
Increase/(decrease) in other deferred liabilities	7,757	7,999
Settlement of treasury lock contracts	0	(27,875)
Other	(3,447)	(2,833)
Net Cash (Used In)/Provided By Operating Activities	209,603	166,165
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(67,311)	(61,358)
Acquisition of businesses, net of cash acquired	(34,811)	0
Cash proceeds on disposal of assets	6,235	3,126
(Increase)/decrease in restricted cash	6,367	550
Net Cash (Used In)/Provided By Investing Activities	(89,520)	(57,682)
FINANCING ACTIVITIES:
Net proceeds from issuance of debt	0	396,816
Payment on retirement of debt	0	(200,000)
Net change in other borrowings	71,775	(42,375)
Net proceeds (repayments) of commercial paper	208,956	(42,975)
Proceeds from sale of treasury stock	23,253	35,246
Treasury stock purchases	(276,003)	(202,934)
Excess tax benefit from stock-based compensation	16,673	10,867
Dividends paid	(61,306)	(55,249)
Purchase of equity award shares	0	(7,614)
Net Cash (Used In)/Provided By Financing Activities	(16,652)	(108,218)
Increase/(Decrease) in Cash and Cash Equivalents	103,431	265
Effect of exchange rate changes on Cash and Cash Equivalents	(7,616)	3,046
Cash and Cash Equivalents at Beginning of Period	253,327	178,167
Cash and Cash Equivalents at End of Period	$ 349,142	$ 181,478